VIDCOVRA
Live / Allowed — Fourth extension granted (statement of use) (as of 11 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 09 Nov 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98263102
- Mark type
- Word mark
- Filed
- 09 Nov 2023
- Published for opposition
- 23 Jul 2024
- Attorney of record
- Terrence J. McAllister
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral diseases and disorders, and for the treatment of pain
Owner
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
- Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US
Prosecution history
- 11 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Sept 2026 — SOU EXTENSION 4 GRANTED
- 10 Sept 2026 — SOU EXTENSION 4 FILED
- 10 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 Mar 2026 — SOU EXTENSION 3 GRANTED
- 02 Mar 2026 — SOU EXTENSION 3 FILED
- 02 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 14 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Sept 2025 — SOU EXTENSION 2 GRANTED
- 13 Sept 2025 — SOU EXTENSION 2 FILED
- 13 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Feb 2025 — SOU EXTENSION 1 GRANTED
- 27 Feb 2025 — SOU EXTENSION 1 FILED